Resource Filter: 2025
EBV-positive Hodgkin lymphoma with immunosuppressive microenvironment during IL-23 inhibitor therapy for psoriasis
Date
CREB5 promotes immunotherapy resistance via tumor-intrinsic collagen matrix deposition
Date
Shared roles of immune and stromal cells in the pathogenesis of human bronchiolitis obliterans syndrome
Date
Spatially resolved integrated omics profiling for ADC targets in Urothelial Carcinoma
Date
Cellular Tropism and Viral Genetics in Appendix Tissue Reservoirs of Subtype C HIV-1 Infected Aviremic Persons
Date
Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis
Date
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity
Date
Immune landscape of adenoid cystic carcinoma: reversible downregulation of HLA class I
Date
Dissecting the immune landscape in EBV+ classical Hodgkin lymphoma following IL-23 inhibition using single-cell hyperplex immunofluorescence analysis: A case report
Date
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Date